Immuneering Corporation Accumulated Other Comprehensive Income
Immuneering Corporation (IMRX) had Accumulated Other Comprehensive Income of -$406.24 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-05
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$406.24K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$241.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $81.33K.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$406.24K 10-Q · filed 2026-08-05 |
| 2026-03-31 | -$241.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $81.33K 10-Q · filed 2026-08-05 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-06 |
| 2024-09-30 | $7.84K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$1.08K 10-Q · filed 2024-05-07 |
| 2023-12-31 | -$778.00 10-K · filed 2025-03-20 |
| 2023-09-30 | $5.61K 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$2.22K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $506.00 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$30.12K 10-K · filed 2024-03-01 |
| 2022-09-30 | -$142.47K 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$181.56K 10-Q · filed 2022-08-10 |
| 2022-03-31 | -$167.40K 10-Q · filed 2022-05-10 |
| 2021-12-31 | -$49.01K 10-K · filed 2023-03-06 |
| 2021-09-30 | -$4.75K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |